Cutler Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Cutler Group’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,700	Closed	-$2K	–	5048
2022 Q4	$2K	Buy	+2,700	New	+$21.8K	﹤0.01%	3862
2022 Q2	–	Sell	-17,500	Closed	-$5K	–	5961
2022 Q1	$5K	Sell	17,500 -34,200	-66%	-$205K	﹤0.01%	4212
2021 Q4	$1K	Buy	51,700 +44,400	+608%	+$282K	﹤0.01%	5248
2021 Q3	$3K	Buy	7,300 +5,600	+329%	+$36K	﹤0.01%	4917
2021 Q2	$4K	Buy	+1,700	New	+$13.7K	﹤0.01%	4682
2021 Q1	–	Sell	-2,100	Closed	-$6K	–	6530
2020 Q4	$6K	Sell	2,100 -3,300	-61%	-$49.5K	﹤0.01%	3582
2020 Q3	$3K	Sell	5,400 -1,700	-24%	-$21.5K	﹤0.01%	3948
2020 Q2	$9K	Buy	+7,100	New	+$89.6K	﹤0.01%	2976
2020 Q1	–	Sell	-6,000	Closed	-$25K	–	4868
2019 Q4	$25K	Buy	+6,000	New	+$53.5K	﹤0.01%	2095

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cutler Group's PRVB Position: Q2 2023 in Review

Cutler Group sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,615 shares — an estimated $38K sold.

Cutler Group first reported a position in PRVB in Q2 2019 and held it in 15 quarters. The position peaked at $94K in Q4 2022. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Cutler Group reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Cutler Group sold 1,615 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $38K.
Cutler Group first reported a position in Provention Bio, Inc. Common Stock in Q2 2019 and held it in 15 quarters.
Cutler Group's Provention Bio, Inc. Common Stock position peaked at $94K in Q4 2022.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.